202 related articles for article (PubMed ID: 8325189)
1. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
4. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
He H; Mennone A; Boyer JL; Cai SY
Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
[TBL] [Abstract][Full Text] [Related]
5. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.
Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Uribe M
Ren Fail; 1995 Jan; 17(1):13-20. PubMed ID: 7770639
[TBL] [Abstract][Full Text] [Related]
6. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
[TBL] [Abstract][Full Text] [Related]
7. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
Azer SA; Canfield PJ; Stacey NH
J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.
Barone M; Maiorano E; Ladisa R; Pece A; Berloco P; Strazzabosco M; Caruso ML; Valentini AM; Ierardi E; Di Leo A; Francavilla A
Virchows Arch; 2004 Jun; 444(6):554-60. PubMed ID: 15071740
[TBL] [Abstract][Full Text] [Related]
10. Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats.
Aldemir M; Geyik MF; Kökoğlu OF; Büyükbayram H; Hoşoğlu S; Yağmur Y
ANZ J Surg; 2003 Sep; 73(9):722-6. PubMed ID: 12956789
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
12. The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.
Sokolovic D; Nikolic J; Kocic G; Jevtovic-Stoimenov T; Veljkovic A; Stojanovic M; Stanojkovic Z; Sokolovic DM; Jelic M
Drug Chem Toxicol; 2013 Apr; 36(2):141-8. PubMed ID: 22385135
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
14. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
17. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction.
Olynyk JK; Yeoh GC; Ramm GA; Clarke SL; Hall PM; Britton RS; Bacon BR; Tracy TF
Am J Pathol; 1998 Feb; 152(2):347-52. PubMed ID: 9466559
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid alleviates cholestasis-induced histophysiological alterations in the male reproductive system of bile duct-ligated rats.
Saad RA; Mahmoud YI
Reprod Toxicol; 2014 Dec; 50():87-97. PubMed ID: 25461907
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
Abdel Kawy HS
Eur J Pharmacol; 2015 Apr; 752():8-17. PubMed ID: 25666386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]